Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma [Phase 2]
Phase 2 study evaluating subcutaneous bevacizumab for relapsed or progressive glioblastoma; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Pembrolizumab +/- Bevacizumab for Recurrent GBM [Phase 2]
Phase 2 trial updating pembrolizumab with or without bevacizumab in recurrent glioblastoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Derivation of Tumor Specific Hybridomas [Phase 1]
A Phase 1 clinical trial at Dartmouth-Hitchcock Medical Center investigating derivation of tumor-specific hybridomas for glioblastoma has be…
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma [Phase 2]
Phase 2 trial of ponatinib in bevacizumab-refractory glioblastoma has completed and results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Perampanel in Seizure Patients With Primary Glial Brain Tumors [Phase 4]
Phase 4 study of perampanel for seizures in patients with primary glial brain tumors completed; results were posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-30Clinical Trial Update: A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor [Phase 1]
A Phase 1 trial evaluating the safety and pharmacokinetics of ABBV-221 in adults with advanced solid tumors likely to overexpress EGFR was t…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients [Phase 2]
A phase 2 trial investigating induction of hypothyroxinemia as an adjunct to standard therapies in glioblastoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma [Phase 2]
Phase 2 trial in glioblastoma comparing dose-dense temozolomide after chemoradiation to temozolomide with all-trans retinoic acid; results p…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse
An observational study of bevacizumab (Avastin) in patients with glioblastoma at first or second relapse has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma [Phase 1]
Phase 1 trial evaluating concurrent macitentan with radiotherapy and temozolomide followed by maintenance macitentan and temozolomide in new…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas [Phase 3]
Phase 3 trial update on β-elemene as maintenance therapy for newly diagnosed malignant gliomas is ongoing, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma [Phase 1]
A Phase 1 trial evaluating temozolomide with ascorbic acid in recurrent high-grade glioma was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas [Phase 3]
Phase III trial investigating adjuvant temozolomide with or without interferon-alpha in newly diagnosed high-grade gliomas, including anapla…
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating Onartuzumab with bevacizumab versus bevacizumab alone or onartuzumab alone in recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma [Phase 3]
Phase III trial of rindopepimut/GM-CSF in newly diagnosed glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma [Phase 2]
Phase 2 trial evaluating nimotuzumab with radiotherapy and temozolomide for glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial of antineoplaston therapy for newly diagnosed glioblastoma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma
Clinical trial on molecular profiling to guide individualized treatment in adults with recurrent/progressive glioblastoma has completed and …
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor [Phase 1]
Phase 1 trial evaluating autologous dendritic cells loaded with brain tumor stem cells for progressive malignant brain tumors has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme [Phase 1]
Phase 1 clinical trial results evaluating the safety and pharmacokinetics of ABT-414 in patients with glioblastoma.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma [Phase 1]
Phase 1 trial evaluating the combination of plerixafor (AMD3100) and bevacizumab for recurrent high-grade glioma has been terminated. The st…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 [Phase 1]
A Phase 1 trial evaluating an autologous heat shock protein gp96 vaccine for glioblastoma/glioma has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma [Phase 1]
The Phase 1 trial of a neoepitope-based personalized vaccine for newly diagnosed glioblastoma was terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas [Phase 1]
Phase 1 feasibility trial evaluating oral 5-fluorocytosine in combination with genetically modified neural stem cells expressing E. coli cyt…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients [Phase 1, Phase 2]
Clinical trial update reports on the safety and efficacy of the ONCOlytic virus TG6002 with its prodrug 5-FC in recurrent glioblastoma, span…